HeyJaredFDA MedWatch
FDA MedWatch is the U.S. Food and Drug Administration’s official safety communication outlet, focused on monitoring, reporting, and disseminating information about risks associated with medical products.
- Indexed articles, last 90 days
- 151
- Latest publication
- Sep 30, 2026
- Audience
- Top 50K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees (opens the original)
Read excerpt
The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its advisory committees— the independent bodies that inform some of the most consequential decisions in American public health. As part of an effort to broaden and strengthen participation on its advisory committees, the FDA is publishing two Federal Register notices: one seeking qualified scientific, technical, and professional voting members a
FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme (opens the original)
Read excerpt
The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals. The two individuals have been charged with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme. The U.S. Food and Drug Administration’s Office of Criminal Investigations assisted with this investigation. “Infiltra
FDA Approves First Treatment for MCT8 Deficiency (opens the original)
Read excerpt
The U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome. Emcitate is the first therapy approved by the FDA to treat symptoms of this very rare, devastating genetic disease. This approval r
FDA intends to evaluate changes to the PMTA regulatory framework (opens the original)
Read excerpt
FDA is carefully reviewing its experience implementing the Premarket Tobacco Product Application (PMTA) rule, as well as recent judicial developments, including a federal lawsuit filed in the U.S. District Court for the Northern District of Texas challenging the current regulatory framework. Based on FDA’s learned experience implementing the 2021 rule, the widespread development of an illicit and unregulated market, and the pace of new product introductions, FDA intends to evaluate changes to th
G. L. Mezzetta Inc. Announces Recall of Mezzetta Brand Golden Greek Peperoncini (Medium Heat) Due to Presence of Pest Contaminant in the Jar (opens the original)
Read excerpt
For generations, families have trusted Mezzetta products on their tables. We take that trust seriously, which is why we want to share what we know about a voluntary recall involving a specific lot of Mezzetta Greek Peppers and the actions we are taking. We’re aware of a video circulating on social media showing a pest contaminant in a jar of Mezzetta Greek Peppers. We’re in contact with the consumer and have moved quickly to investigate the situation and initiate a voluntary recall. At this time
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.